M. J. Biopharm Private Limited
Indian Pharmaceutical Exporter ยท Diabetes & Endocrine Specialist ยท $22.4M Total Trade ยท DGFT Verified
M. J. Biopharm Private Limited is an Indian pharmaceutical exporter with a total trade value of $22.4M across 6 products in 4 therapeutic categories. Based on 476 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Insulin ($18.9M), Meropenem ($2.1M), Imipenem ($678.9K).
M. J. Biopharm Private Limited โ Export Portfolio & Destination Treemap

Who is M. J. Biopharm Private Limited? โ Company Overview & Market Position
M. J. Biopharm Private Limited is a privately held biopharmaceutical company established on June 27, 2002, in Pune, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24234PN2002PTC158855. As of March 31, 2023, M. J. Biopharm reported an authorized share capital of โน400 million and a paid-up capital of โน230.06 million. The company specializes in the manufacture of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, with a focus on diabetes and endocrine treatments, advanced antibiotics, and advanced diabetes medications.
The company's registered office is located at Plot No. 18, IT Park, Hinjawadi Phase II, Near Emcure Industrial, Pune, Maharashtra, India - 411057. M. J. Biopharm operates manufacturing facilities in Pune and Navi Mumbai, Maharashtra, with a workforce of approximately 524 employees. The company's website is www.mjgroup.co.in.